Abdominal iron deposition: Metabolism, MR findings, and clinical importance

Radiology

Volumn 199, Issue 1, 1996, Pages 13-22

  Siegelman, Evan S ^a   Mitchell, Donald G ^b   Semelka, Richard C ^c  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Abdomen, acute conditions; Iron; Magnetic resonance (MR), utilization; State of art reviews

Indexed keywords

CONTRAST MEDIUM; IRON OXIDE;

ANGIOSARCOMA; BIOACCUMULATION; ERYTHROPOIESIS; HEMOCHROMATOSIS; INTRAVASCULAR HEMOLYSIS; IRON METABOLISM; IRON OVERLOAD; IRON STORAGE; IRON TRANSPORT; LIVER CIRRHOSIS; PRIORITY JOURNAL; REVIEW; SIDEROSIS; TREATMENT PLANNING;

EID: 0029919699     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.199.1.8633135     Document Type: Review

References (170)

1. Halliday JW, Powell LW. Hereditary hemochromatosis and other diseases associated with iron overload. In: Lauffer RB, ed. Iron and human disease. Boca Raton, Fla: CRC, 1992; 131-160.
2. Bernat I. Iron metabolism. New York, NY: Plenum, 1983.
3. Brittenham GM. The red cell cycle. In: Brock JH, Halliday JW, Pippard MJ, Powell LW, eds. Iron metabolism in health and disease. Philadelphia, Pa: Saunders, 1994; 31-62.
4. Powell LW, Jazwinska E, Halliday JW. Primary iron overload. In: Brock JH, Halliday JW, Pippard MJ, Powell LW, eds. Iron metabolism in health and disease. Philadelphia, Pa: Saunders, 1994; 227-270.
5. Pippard MJ. Secondary iron overload. In: Brock JH, Halliday JW, Pippard MJ, Powell LW, eds. Iron metabolism in health and disease. Philadelphia, Pa: Saunders, 1994; 271-309.
6. Stark DD. Hepatic iron overload: paramagnetic pathology. Radiology 1991; 179: 333-335.
7. Bradley WG, Jr. MR appearance of hemorrhage in the brain. Radiology 1993; 189: 15-26.
8. Conrad ME, Umbreit JN, Moore EG, Parmley RT. Hereditary hemochromatosis: a prevalent disorder of iron metabolism with an elusive etiology. Am J Hematol 1994; 47:218-224.
9. MacLaren GD, Muir WA, Kellermeyer RW. Iron overload disorders: natural history, pathogenesis, diagnosis, and therapy. Crit Rev Clin Lab Sci 1984; 19: 205-266.
10. Rouault TA. Hereditary hemochromatosis. JAMA 1993; 269:3152-3154.
11. Bonkovsky HL. Iron and the liver. Am J Med Sci 1991; 301:32-43.
12. Olynyk JK, Bacon BR. Hereditary hemochromatosis: detecting and correcting iron overload. Postgrad Med 1994; 96:151-158, 161, 165.
13. Fillet G, Beguin Y, Baldelli L. Model of reticuloendothelial iron metabolism in humans: abnormal behavior in idiopathic hemochromatosis and inflammation. Blood 1989; 74:844-851.
14. Flanagan PR, Lam D, Banerjee D, Valberg LS. Ferritin release by mononuclear cells in hereditary hemochromatosis. J Lab Clin Med 1989; 113:145-150.
15. Buffone GJ, Beck JR. Cost-effectiveness analysis for evaluation of screening programs: hereditary hemochromatosis. Clin Chem 1994; 40:1631-1636.
16. Edwards CQ, Kushner JP. Screening for hemochromatosis. N Engl J Med 1993; 328:1616-1620.
17. Phatak PD, Guzman G, Woll JE, Robeson A, Phelps CE. Cost-effectiveness of screening for hereditary hemochromatosis. Arch Intern Med 1994; 154:769-776.
18. Sallie RW, Reed WD, Shilkin KB. Confirmation of the efficacy of hepatic tissue iron index in differentiating genetic haemochromatosis from alcoholic liver disease complicated by alcoholic haemosiderosis. Gut 1991; 32:207-210.
19. Summers KM, Halliday JW, Powell LW. Identification of homozygous hemochromatosis subjects by measurement of hepatic iron index. Hepatology 1990; 12:20-25.
20. Bonkovsky HL, Slaker DP, Bills EB, Wolf DC. Usefulness and limitations of laboratory and hepatic imaging studies in iron-storage disease. Gastroenterology 1990; 99:1079-1091.
21. Grindon AJ. Blood donation from patients with hemochromatosis. JAMA 1993; 270:880.
22. Adams PC, Speechley M, Kertesz AE. Long-term survival analysis in hereditary hemochromatosis. Gastroenterology 1991; 101:368-372.
23. Niederau C, Fischer R, Sonnenberg A, Stremmel W, Tranpisch HJ, Strohmeyer G. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med 1985; 313:1256-1262.
24. Deugnier YM, Guyader D, Crantock L, et al. Primary liver cancer in genetic hemochromatosis: a clinical, pathological, and pathogenetic study of 54 cases. Gastroenterology 1993; 104:228-234.
25. Niederau C, Strohmeyer G, Stremmel W. Epidemiology, clinical spectrum and prognosis of hemochromatosis. Adv Exp Med Biol 1994; 356:293-302.
26. Thulborn KR, Brady TJ. Iron in magnetic resonance imaging of cerebral hemorrhage. Magn Reson Q 1989; 5:23-38.
27. Engelhardt R, Langkowski JH, Fischer R, et al. Liver iron quantification: studies in aqueous iron solutions, iron overloaded rats, and patients with hereditary hemochromatosis. Magn Reson Imaging 1994; 12:999-1007.
28. Andersen PB, Birgegard G, Nyman R, Hemmingsson A. Magnetic resonance imaging in idiopathic hemochromatosis. Eur J Haematol 1991; 47:174-178.
29. Bondestam S, Lamminen A, Anttila VJ, Ruutu T, Ruutu P. Magnetic resonance imaging of transfusional hepatic iron overload. Br J Radiol 1994; 67:339-341.
30. Brasch RC, Wesbey GE, Gooding CA, Koerper MA. Magnetic resonance imaging of transfusional hemosiderosis complicating thalassemia major. Radiology 1984; 150:767-771.
31. Burke DM, McCartney WH, Lesesne HR, Bryan JAD, Schiebler ML. Secondary hemochromatosis: diagnosis by MRI. Am Fam Physician 1991; 43:771-774.
32. Chan PC, Liu P, Cronin C, Heathcote J, Uldall R. The use of nuclear magnetic resonance imaging in monitoring total body iron in hemodialysis patients with hemosiderosis treated with erythropoietin and phlebotomy. Am J Kidney Dis 1992; 19:484-489.
33. Chezmar JL, Nelson RC, Malko JA, Bernardino ME. Hepatic iron overload: diagnosis and quantification by noninvasive imaging. Gastrointest Radiol 1990; 15:27-31.
34. Dixon RM, Styles P, al-Refaie FN, et al. Assessment of hepatic iron overload in thalassemic patients by magnetic resonance spectroscopy. Hepatology 1994; 19:904-910.
35. Gandon Y, Guyader D, Heautot JF, et al. Hemochromatosis: diagnosis and quantification of liver iron with gradient-echo MR imaging. Radiology 1994; 193:533-538.
36. Gomori JM, Horev G, Tamary H, et al. Hepatic iron overload: quantitative MR imaging. Radiology 1991; 179:367-369.
37. Guyader D, Gandon Y, Robert JY, et al. Magnetic resonance imaging and assessment of liver iron content in genetic hemochromatosis. J Hepatol 1992; 15:304-308.
38. Housman JF, Chezmar JL, Nelson RC. Magnetic resonance imaging in hemochromatosis: extrahepatic iron deposition. Gastrointest Radiol 1989; 14:59-60.
39. Jensen PD, Jensen FT, Christensen T, Ellegaard J. Non-invasive assessment of tissue iron overload in the liver by magnetic resonance imaging. Br J Haematol 1994; 87:171-184.
40. Johnston DL, Rice L, Vick GWd, Hedrick TD, Rokey R. Assessment of tissue iron overload by nuclear magnetic resonance imaging. Am J Med 1989; 87:40-47.
41. Kaltwasser JP, Gottschalk R, Schalk KP, Hartl W. Non-invasive quantitation of liver iron-overload by magnetic resonance imaging. Br J Haematol 1990; 74:360-363.
42. Kinney TB, Deluca SA. Idiopathic hemochromatosis. Am Fam Physician 1991; 44: 873-875.
43. Miller FH, Fisher MR, Soper W, Gore RM. MRI of hepatic iron deposition in patients with renal transplant. Gastrointest Radiol 1991; 16:229-233.
44. Querfeld U, Dietrich R, Taira RK, Kangarloo H, Salusky IB, Fine RN. Magnetic resonance imaging of iron overload in children treated with peritoneal dialysis. Nephron 1988; 50:220-224.
45. Rocchi E, Cassanelli M, Borghi A, et al. Magnetic resonance imaging and different levels of iron overload in chronic liver disease. Hepatology 1993; 17:997-1002.
46. Rocchi E. Magnetic resonance and hepatic siderosis. Recenti Prog Med 1994; 85:447-451.
47. Schettini F, De Mattia D, Cavallo L, et al. Nuclear magnetic resonance and iron overload in thalassemia. Minerva Pediatr 1991; 43:777-781.
48. Siegelman ES, Mitchell DG, Rubin R, et al. Parenchymal versus reticuloendothelial iron overload in the liver: distinction with MR imaging. Radiology 1991; 179:361-366.
49. Siegelman ES, Mitchell DG, Outwater E, Munoz SJ, Rubin R. Idiopathic hemochromatosis: MR imaging findings in cirrhotic and precirrhotic patients. Radiology 1993; 188:637-641.
50. Stark DD, Bass NM, Moss AA, et al. Nuclear magnetic resonance imaging of experimentally induced liver disease. Radiology 1983; 148:743-751.
51. Stark DD, Moseley ME, Bacon BR, et al. Magnetic resonance imaging and spectroscopy of hepatic iron overload. Radiology 1985; 154:137-142.
52. Thomsen C, Wiggers P, Ring-Larsen H, et al. Identification of patients with hereditary haemochromatosis by magnetic resonance imaging and spectroscopic relaxation time measurements. Magn Reson Imaging 1992; 10:867-879.
53. Villari N, Caramella D, Lippi A, Guazzelli C. Assessment of liver iron overload in thalassemic patients by MR imaging. Acta Radiol 1992; 33:347-350.
54. Yoon DY, Choi BI, Han JK, Han MC, Park MO, Suh SJ. MR findings of secondary hemochromatosis: transfusional vs erythropoietic. J Comput Assist Tomogr 1994; 18:416-419.
55. Ludwig J, Batts KP, Moyer TP, Baldus WP, Fairbanks VF. Liver biopsy diagnosis of homozygous hemochromatosis: a diagnostic algorithm. Mayo Clin Proc 1993; 68:263-267.
56. Jensen PD, Jensen FT, Christensen T, Ellegaard J. Evaluation of transfusional iron overload before and during iron chelation by magnetic resoance imaging of the liver and determination of serum ferritin in adult non-thalassaemic patients. Br J Haematol 1995; 89:880-889.
57. Harada M, Hirai K, Iwai I, et al. A case of secondary hemochromatosis, in which MRI is useful to evaluate therapeutic effect. Rinsho Hoshasen 1990; 35:1081-1084.
58. Niderau C, Berger M, Stremmel W, et al. Hyperinsulinaemia in non-cirrhotic haemochromatosis: impaired hepatic insulin degradation? Diabetolgia 1984; 26:441-444.
59. Dudiak KM. Abdominal case of the day: hepatocellular carcinoma in a patient with primary hemochromatosis. AJR 1993; 160: 1325-1327.
60. Johnson CD. Magnetic resonance imaging of the liver: current clinical applications. Mayo Clin Proc 1993; 68:147-156.
61. Duane P, Raja KB, Simpson RJ, Peters TJ. Intestinal iron absorption in chronic alcoholics. Alcohol Alcohol 1992; 27:539-544.
62. Chapman RW, Morgan MY, Laulicht M, Hoffbrand AV, Sherlock S. Hepatic iron stores and markers of iron overload in alcoholics and patients with idiopathic hemochromatosis. Dig Dis Sci 1982; 27: 909-916.
63. Chapman RW, Morgan MY, Bell R, Sherlock S. Hepatic iron uptake in alcoholic liver disease. Gastroenterology 1983; 84: 143-147.
64. Powell LW, Bassett ML, Halliday JW. Hemochromatosis: 1980 update. Gastroenterology 1980; 78:374-381.
65. Whipple GH. Mediterranean disease: thalassemia (erythroblastic anemia of Cooley) - associated pigment abnormalities simulating hemochromatosis. J Pediatr 1936; 9:279-311.
66. Bowdler AJ, Huehns ER. Thalassaemia minor complicated by excessive iron storage. Br J Haematol 1963; 9:13-24.
67. Ellis JT, Schulman I, Smith CH. Generalized siderosis with fibrosis of liver and pancreas in Cooley's anemia with observations on the pathogenesis of the siderosis and fibrosis. Am J Pathol 1954; 30:287-310.
68. Siegelman ES, Outwater E, Hanau CA, et al. Abdominal iron distribution in sickle cell disease: MR findings in transfusion and nontransfusion dependent patients. J Comput Assist Tomogr 1994; 18:63-67.
69. Mitchell GG, Stark DD. Hepatobiliary MRI. St Louis, Mo: Mosby-Year Book, 1992.
70. Conrad ME. Sickle cell disease and hemochromatosis. Am J Hematol 1991; 38: 150-152.
71. Brink B, Disler P, Lynch S, Jacobs P, Charlton R, Bothwell T. Patterns of iron storage in dietary iron overload and idiopathic hemochromatosis. J Lab Clin Med 1976; 88:725-731.
72. Gordeuk V, Mukiibi J, Hasstedt SJ, et al. Iron overload in Africa: interaction between a gene and dietary iron content. N Engl J Med 1992; 326:95-100.
73. Higginson J, Gerritsen T, Walker ARP. Siderosis in the Bantu of Southern Africa. Am J Pathol 1953; 29:779-816.
74. Bacon BR. Causes of iron overload. N Engl J Med 1992; 326:126-127.
75. Jandl JH. Blood: textbook of hematology. Boston, Mass: Little, Brown, 1987.
76. Oliveieri NF, Brittenham GM, Matsui D, et al. Iron-chelation therapy with oral deferiprone in patients with thalassemia major. N Engl J Med 1995; 332:918-922.
77. Brittenham GM, Griffith PM, Nienhuis AW, et al. Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N Engl J Med 1994; 331:567-573.
78. Lu JP, Hayashi K. Selective iron deposition in pancreatic islet B cells of transfusional iron-overloaded autopsy cases. Pathol Int 1994; 44:194-199.
79. Schafer AI, Cheron RG, Dluhy R, et al. Clinical consequences of acquired transfusional iron overload in adults. N Engl J Med 1981; 304:319-324.
80. Zuppinger K, Molinari B, Hirt A, et al. Increased risk of diabetes mellitus in beta-thalassemia major due to iron overload. Helv Paediatr Acta 1979; 34:197-207.
81. Weissleder R. Liver MR imaging with iron oxides: toward consensus and clinical practice. Radiology 1994; 193:593-595.
82. Terada T, Nakanuma Y. Iron-negative foci in siderotic macroregenerative nodules in human cirrhotic liver: a marker of incipient neoplastic lesions. Arch Pathol Lab Med 1989; 113:916-920.
83. Cho JS, Kim EE, Varma DG, Wallace S. MR imaging of hepatosplenic candidiasis superimposed on hemochromatosis. J Comput Assist Tomogr 1990; 14:774-776.
84. Guyader D, Gandon Y. MR of hepatocellular carcinoma in idiopathic hemochromatosis (letter). AJR 1988; 151:833.
85. Grandin C, Van Beers BE, Robert A, Gigot J, Geubel A, Pringot J. Benign hepatocellular tumors: MRI after superparamagnetic iron oxide administration. J Comput Assist Tomogr 1995; 19:412-418.
86. Bellin MF, Zaim S, Auberton E, et al. Liver metastases: safety and efficacy of detection with superparamagnetic iron oxide in MR imaging. Radiology 1994; 193:657-663.
87. Denys A, Arrive L, Servois V, et al. Hepatic tumors: detection and characterization at 1-T MR imaging enhanced with AMI-25. Radiology 1994; 193:665-669.
88. Duda SH, Laniado M, Kopp AF, et al. Superparamagnetic iron oxide: detection of focal liver lesions at high-field-strength MR imaging. J Magn Reson Imaging 1994; 4:309-314.
89. Ferrucci JT, Stark DD. Iron oxide-enhanced MR imaging of the liver and spleen: review of the first 5 years. AJR 1990; 155:943-950.
90. Fretz CJ, Stark DD, Metz CE, et al. Detection of hepatic metastases: comparison of contrast-enhanced CT, unenhanced MR imaging, and iron oxide-enhanced MR imaging. AJR 1990; 155:763-770.
91. Halavaara JT, Lamminen AE, Bondestam S, Standertskjold-Nordenstam CG, Hamberg LM. Detection of focal liver lesions with superparamagnetic iron oxide: value of STIR and SE imaging. J Comput Assist Tomogr 1994; 18:897-904.
92. Hamm B, Reichel M, Vogl T, Taupitz M, Wolf KJ. Superparamagnetic iron particles: the clinical results in the MR diagnosis of liver metastases. ROFO 1994; 160:52-58.
93. Hirohashi S, Uchida H, Ohimichi R, Kitano S, Tanaka M, Ohishi H. Usefulness of superparamagnetic iron oxide particles in the detection of hepatocellular carcinoma by MR imaging. Nippon Igaku Hoshasen Gakkai Zasshi 1993; 53:469-471.
94. Hirohashi S, Hirohashi R, Uchida H, et al. Usefulness of superparamagnetic iron oxide particle (AMI-25) enhanced MR imaging for the diagnosis of liver tumors: comparison with contrast enhanced CT. Nippon Igaku Hoshasen Gakkai Zasshi 1994; 54:776-783.
95. Kawamori Y, Matsui O, Kadoya M, Yoshikawa J, Demachi H, Takashima T. Differentiation of hepatocellular carcinomas from hyperplastic nodules induced in rat liver with ferrite-enhanced MR imaging. Radiology 1992; 183:65-72.
96. Marchai G, Van Hecke P, Demaerel P, et al. Detection of liver metastases with superparamagnetic iron oxide in 15 patients: results of MR imaging at 1.5 T. AJR 1989; 152:771-775.
97. Reimer P, Rummeny EJ, Daldrup HE, et al. Clinical results with Resovist: a phase 2 clinical trial. Radiology 1995; 195:489-496.
98. Vogl TJ, Hammerstingl R, Pegios W, et al. The value of the liver-specific superparamagnetic contrast medium AMI-25 for the detection and differential diagnosis of primary liver tumors versus metastases. ROFO 1994; 160:319-328.
99. Winter TC, Freeny PC, Nghiem HV, et al. MR imaging with iv superparamagnetic iron oxide: efficacy in the detection of focal hepatic lesions. AJR 1993; 161:1191-1198.
100. Yamamoto K, Shimizu T, Hiraishi K, et al. Evaluation of AMI-25 enhanced MR imaging and enhanced helical CT for liver tumors. Nippon Igaku Hoshasen Gakkai Zasshi 1995; 55:1-6.
101. Yamamoto H, Yamashita Y, Yoshimatsu S, et al. Hepatocellular carcinoma in cirrhotic livers: detection with unenhanced and iron oxide-enhanced MR imaging. Radiology 1995; 195:106-112.
102. Yoshikawa K, Sasaki Y, Ogawa N, Sakuma S. Clinical application of AMI-25 (superparamagnetic iron oxide) for the MR imaging of hepatic tumors: a multicenter clinical phase III study. Nippon Igaku Hoshasen Gakkai Zasshi 1994; 54:137-153.
103. Hagspiel KD, Neidl KFW, Eichenberger AC, Weder W, Marincek B. Detection of liver metastases: comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, introperative US, and percutaneous US. Radiology 1995; 196:471-478.
104. Ros PR, Freeny PC, Harms SE, et al. Hepatic MR imaging with Ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions. Radiology 1995; 196:481-488.
105. Grangier C, Tourniaire J, Mentha G, et al. Enhancement of liver hemangiomas on T1-weighted MR SE images by superparamagnetic iron oxide particles. J Comput Assist Tomogr 1994; 18:888-896.
106. Yamamoto H, Yamashita Y, Yoshimatsu S, Baba Y, Takahashi M. MR enhancement of hepatoma by superparamagnetic iron oxide (SPIO) particles. J Comput Assit Tomogr 1995; 19:665-667.
107. Koslow SA, Davis PL, DeMarino GB, Peel RL, Baron RL, Van Thiel DH. Hyperintense cirrhotic nodules on MRI. Gastrointest Radiol 1991; 16:339-341.
108. Murakami T, Marukawa T, Kuroda C, et al. Siderotic regenerating nodules in liver cirrhosis: evaluation by gradient echo (FLASH) imaging 1.5T. Nippon Igaku Hoshasen Gakkai Zasshi 1989; 49:1427-1429.
109. Murakami T, Kuroda C, Marukawa T, et al. Regenerating nodules in hepatic cirrhosis: MR findings with pathologic correlation. AJR 1990; 155:1227-1231.
110. Murakami T, Nakamura H, Kuroda C, et al. Siderotic nodules in hepatic cirrhosis disappearing after biliary hemorrhage: MR imaging. J Comput Assist Tomogr 1991; 15:1039-1041.
111. Murakami T, Nakamura H, Hori S, et al. CT and MRI of siderotic regenerating nodules in hepatic cirrhosis. J Comput Assist Tomogr 1992; 16:578-582.
112. Mitchell DG, Rubin R, Siegelman ES, Burk DL, Jr, Rifkin MD. Hepatocellular carcinoma within siderotic regenerative nodules: appearance as a nodule within a nodule on MR images. Radiology 1991; 178:101-103.
113. Ohtomo K, Itai Y, Ohtomo Y, Shiga J, Iio M. Regenerating nodules of liver cirrhosis: MR imaging with pathologic correlation. AJR 1990; 154:505-507.
114. Terada T, Kadoya M, Nakanuma Y, Matsui O. Iron-accumulating adenomatous hyperplastic nodule with malignant foci in the cirrhotic liver: histopathologic, quantitative iron, and magnetic resonance imaging in vitro studies. Cancer 1990; 65: 1994-2000.
115. Van Beers B, Trigaux JP, Grandin C, et al. Regenerative nodules in hepatic cirrhosis: value of gradient-echo MR imaging with a surface coil. Acta Radiol 1992; 33:245-250.
116. Terada T, Nakanuma Y. Survey of iron-accumulative macroregenerative nodules in cirrhotic livers. Hepatology 1989; 10: 851-854.
117. Herbert V, Shaw S, Jayatilleke E, Stopler-Kasdan T. Most free-radical injury is iron-related: it is promoted by iron, hemin, holoferritin and vitamin C, and inhibited by desferoxamine and apoferritin. Stem Cells (Dayt) 1994; 12:289-303.
118. Knekt P, Reunanen A, Takkunen H, Aromaa A, Heliovaara M, Hakulinen T. Body iron stores and risk of cancer. Int J Cancer 1994; 56:379-382.
119. Sussman HH. Iron in cancer. Pathobiology 1992; 60:2-9.
120. Weinberg ED. Roles of iron in neoplasia: promotion, prevention, and therapy. Biol Trace Elem Res 1992; 34:123-140.
121. Brock JH. Iron in infection, immunity, inflammation and neoplasia. In: Brock JH, Halliday JW, Pippard MJ, Powell LW, eds. Iron metabolism in health and disease. Philadelphia, Pa: Saunders, 1994; 353-389.
122. Hann HW, Kim CY, London WT, Blumberg BS. Increased serum ferritin in chronic liver disease: a risk factor for primary hepatocellular carcinoma. Int J Cancer 1989; 43:376-379.
123. Stevens RG. Iron and cancer. In: Lauffer RB, ed. Iron and human disease. Boca Raton, Fla: CRC, 1992; 333-348.
124. Sadek AG, Mitchell DG, Siegelman ES, Outwater EK, Matteucci T, Hann HWL. Early hepatocellular carcinoma that develops within macroregenerative nodules: growth rate depicted at serial MR imaging. Radiology 1995; 195:753-756.
125. Murphy FB, Bernardino ME. MR imaging of focal hemochromatosis. J Comput Assist Tomogr 1986; 10:1044-1046.
126. Kadoya M, Matsui O, Kitagawa K, et al. Segmental iron deposition in the liver due to decreased intrahepatic portal perfusion: findings at MR imaging. Radiology 1994; 193:671-676.
127. Kawamori Y, Matsui O, Kitagawa K, et al. Segmental hepatic iron deposition due to peripheral portal vein tumor thrombus: MR features. J Comput Assist Tomogr 1991; 15:1042-1044.
128. Arrive L, Flejou JF, Vilgrain V, et al. Hepatic adenoma: MR findings in 51 pathologically proved lesions. Radiology 1994; 193:507-512.
129. Coombs RJ, Woldenberg LS, Skeel RT, Bishara HM, Merrick HW. Magnetic resonance imaging of hepatic adenoma. Clin Imaging 1990; 14:44-47.
130. Gabata T, Matsui O, Kadoya M, et al. MR imaging of hepatic adenoma. AJR 1990; 155:1009-1011.
131. Gaa J, Lee MJ, Saini S. Case report: haemorrhagic hepatic adenoma - MR features. Clin Radiol 1994; 49:719-720.
132. Paulson EK, McClellan JS, Washington K, Spritzer CE, Meyers WC, Baker ME. Hepatic adenoma: MR characteristics and correlation with pathologic findings. AJR 1994; 163:113-116.
133. Powers C, Ros PR, Stoupis C, Johnson WK, Segel KH. Primary liver neoplasms: MR imaging with pathologic correlation. RadioGraphics 1994; 14:459-482.
134. Chung KY, Mayo-Smith WW, Saini S, Rahmouni A, Golli M, Mathieu D. Hepatocellular adenoma: MR imaging features with pathologic correlation. AJR 1995; 165: 303-308.
135. Moon WK, Kim WS, Kim IO, et al. Hepatic choriocarcinoma in a neonate: MR appearance. J Comput Assist Tomogr 1993; 17:653-655.
136. Premkumar A, Sanders L, Marincola F, Feuerstein I, Concepcion R, Schwartzentruber D. Visceral metastases from melanoma: findings on MR imaging. AJR 1992; 158:293-298.
137. Ferris JD, Bloom PA, Goddard PR, Collins C. Quantification of melanin and iron content in uveal malignant melanomas and correlation with magnetic resonance image. Br J Ophthalmol 1993; 77:297-301.
138. Deiss A. Destruction of erythrocytes. In: Lee GR, Bithell TC, Foerster J, Athens JW, Lukens JN, eds. Wintrobe's clinical hematology. Vol 1. Philadelphia, Pa: Lea & Febiger, 1993; 195-222.
139. Kino K, Mizumoto K, Watanabe J, Tsunoo H. Immunohistochemical studies on hemoglobin-haptoglobin and hemoglobin catabolism sites. J Histochem Cytochem 1987; 35:381-386.
140. Bunn HF, Jandl JH. The renal handling of hemoglobin. J Exp Med 1969; 129:925-934.
141. Suzukawa K, Ninomiya H, Mitsuhashi S, Anno I, Nagasawa T, Abe T. Demonstration of the deposition of hemosiderin in the kidneys of patients with paroxysmal nocturnal hemoglobinuria by magnetic resonance imaging. Intern Med 1993; 32: 686-690.
142. Kim SH, Han MC, Kim S, Lee JS. MR imaging of acute renal cortical necrosis: a case report. Acta Radiol 1992; 33:431-433.
143. Lee GR. Paroxysmal nocturnal hemoglobinuria. In: Lee GR, Bithell TC, Foerster J, Athens JW, Lukens JN, eds. Wintrobe's clinical hematology. 9th ed. Vol 1. Philadelphia, Pa: Lea & Febiger, 1993; 1232-1244.
144. Rotoli B, Luzzatto L. Paroxysmal nocturnal hemoglobinuria. Semin Hematol 1989; 26:201-207.
145. Huang CC, Cheng YF, Kuo CY, Lee TY, Tsai CC. Magnetic resonance imaging of the kidneys in paroxysmal nocturnal hemoglobinuria. Chang Keng I Hsueh 1994; 17:100-104.
146. Kim SH, Han MC, Lee JS, Kim S. Paroxysmal nocturnal hemoglobinuria: case report of MR imaging and CT findings. Acta Radiol 1991; 32:315-316.
147. Lupetin AR. Magnetic resonance appearance of the kidneys in paroxysmal nocturnal hemoglobinuria. Urol Radiol 1986; 8:101-103.
148. Mulopulos GP, Turner DA, Schwartz MM, Murakami ME, Clark JW. MRI of the kidneys in paroxysmal nocturnal hemoglobinuria. AJR 1986; 146:51-52.
149. Rigauts H, Baert AL, Veekmans P, Marchai G, Martens A, Zachee P. MRI findings in renal cortical hemosiderosis. Eur J Radiol 1992; 15:239-241.
150. Roubidoux MA. MR of the kidneys, liver, and spleen in paroxysmal nocturnal hemoglobinuria. Abdom Imaging 1994; 19:168-173.
151. Tanaka YO, Anno I, Itai Y, Abe T. Paroxysmal nocturnal hemoglobinuria: MR findings. J Comput Assist Tomogr 1993; 17:749-753.
152. Clark DA, Butler SA, Braren V, Hartmann RC, Jenkins DEJ. The kidneys in paroxysmal nocturnal hemoglobinuria. Blood 1981; 57:83-89.
153. Riley AL, Ryan LM, Roth DA. Renal proximal tubular dysfunction and paroxysmal nocturnal hemoglobinuria. Am J Med 1976; 62:125-129.
154. Lande IM, Glazer GM, Sarnaik S, Aisen A, Rucknagel D, Martel W. Sickle-cell nephropathy: MR imaging. Radiology 1986; 158:379-383.
155. Allon M. Renal abnormalities in sickle cell disease. Arch Int Med 1990; 150:501-504.
156. Serjeant GR. Sickle cell disease. 2nd ed. New York, NY: Oxford University Press, 1992.
157. Anonymous. Hantavirus disease. Lancet 1990; 336:407-408.
158. Kim SH, Kim S, Lee JS, et al. Hemorrhagic fever with renal syndrome: MR imaging of the kidney. Radiology 1990; 175:823-825.
159. Ko KW. Haemorrhagic fever with renal syndrome: clinical aspects. Pediatr Nephrol 1992; 6:197-200.
160. Mustonen J, Helin H, Pietila K, et al. Renal biopsy findings and clinicopathologic correlations in nephropathia epidemica. Clin Nephrol 1994; 41:121-126.
161. Adler DD, Glazer GM, Aisen AM. MRI of the spleen: normal appearance and findings in sickle-cell anemia. AJR 1986; 147: 843-845.
162. Diggs LW. Siderofibrosis of spleen in sickel cell anemia. JAMA 1935; 104:538-541.
163. Minami M, Itai Y, Ohtomo K, et al. Siderotic nodules in the spleen: MR imaging of portal hypertension. Radiology 1989; 172:681-684.
164. Sagoh T, Itoh K, Togashi K, et al. Gamna-Gandy bodies of the spleen: evaluation with MR imaging. Radiology 1989; 172: 685-687.
165. Falk S, Krishnan J, Meis JM. Primary angiosarcoma of the spleen: a clinicopathologic study of 40 cases. Am J Surg Pathol 1993; 17:959-970.
166. Dachman AH. Lymphoma and primary splenic neoplasms. In: Dachman AH, Friedman AC, eds. Radiology of the spleen. St Louis, Mo: Mosby-Year Book, 1993; 94-137.
167. Ha HK, Kim HH, Kim BK, Han JK, Choi BI. Primary angiosarcoma of the spleen: CT and MR imaging. Acta Radiol 1994; 35:455-458.
168. Kaneko K, Onitsuka H, Murakami J, et al. MRI of primary spleen angiosarcoma with iron accumulation. J Comput Assist Tomogr 1992; 16:298-300.
169. Fajadet P, Poey C, Giron J, et al. Hepatic angiosarcoma: CT and MRI aspects - a case report and review of the literature. Ann Radiol (Paris) 1990; 33:260-263.
170. Williams L, Kumar A, Aggarwal S. Calcified splenic metastasis from gastric carcinoma. Abdom Imaging 1995; 20:312-314.